Mast Cell Blockers and Atopic Eczema

  • L. Businco
  • A. Cantani


The concept of foods which are forbidden and should not be eaten goes back to the Garden of Eden and subsequently to suggestions of Hippocrates and Lucretius. Cow’s milk could cause gastric upset and hives according to Hippocrates. Furthermore, the Roman poet Lucretius stated “one man’s meat is another man’s poison” [1].


Mast Cell Atopic Eczema Food Allergy Sodium Cromoglycate Systemic Mastocytosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Businco L, Benincori N, Cantani A (1984) Epidemiology, incidence and clinical aspects of food allergy. In: Reinhardt MC, Bellanti JA, Rossi E (eds) Food allergies and intolerances: a Nestlé Foundation workshop. Lausanne, 7–9 Sept 1983. Ann Allergy 53: 615Google Scholar
  2. 2.
    Sampson HA (1988) Immunologically mediated food allergy: the importance of food challenge procedures. Ann Allergy 60: 262PubMedGoogle Scholar
  3. 3.
    Businco L, Benincori N, Cantani A (1986) The spectrum of food allergy in infancy and childhood. Ann Allergy 57: 213PubMedGoogle Scholar
  4. 4.
    Businco L, Cantani A, Monteleone AM, Ziruolo MG (1988) Atopic dermatitis in children: an update. Folia Allergol Immunol Clin 35: 41Google Scholar
  5. 5.
    Kay AB, Walsh GM, Moqbel R et al. (1987) Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol 80: 1PubMedCrossRefGoogle Scholar
  6. 6.
    Skedinger MC, Augustine NH, Morris EZ et al. (1987) Effect of disodium cromoglycate on neutrophil movement and intracellular calcium mobilization. J Allergy Immunol 80: 573CrossRefGoogle Scholar
  7. 7.
    Enerbäck L (1966) Mast cells in rat gastrointestinal mucosa. II. Dye binding and metachromatic properties. Acta Pathol Microbial Scand A 66: 303Google Scholar
  8. 8.
    Bienenstock J (1988) An update on mast cell heterogeneity. J Allergy Clin Immunol 81: 763PubMedCrossRefGoogle Scholar
  9. 9.
    Fox CC, Wolf EJ, Kagey-Sobotka A, Lichtenstein LM (1988) Comparison of human lung and intestinal mast cells. J Allergy Clin Immunol 81: 89PubMedCrossRefGoogle Scholar
  10. 10.
    Businco L, Cantani A, Businco E, Pepys J (1984) Systemic mastocytosis in a 5-year-old child: Successful treatment with disodium cromoglycate. Clin Allergy 14: 147Google Scholar
  11. 11.
    Businco L, Cantani A, Meglio P, Giampietro PG (1990) Sodium cromoglycate in the management of food allergy in children. In: Harms HK, Wahn U (eds) Food allergy in infancy and childhood. Springer, Berlin Heidelberg New YorkGoogle Scholar
  12. 12.
    Businco L, Benincori N, Cantani A et al. (1986) Double-blind crossover trial with oral sodium cromoglycate in children with atopic dermatitis due to food allergy. Ann Allergy 57: 433PubMedGoogle Scholar
  13. 13.
    Atherton DJ, Soothill JF, Elvidge J (1982) A controlled trial of oral sodium cromoglycate in atopic eczema. Br J Dermatol 126: 681–685CrossRefGoogle Scholar
  14. 14.
    Harris JM, Graham P, Hall-Smith SP et al. (1983)The use of sodium cromoglycate and exclusion diets in childhood atopic eczema. Proceedings of the 2nd Fisons Food Allergy Workshop. Harrogate, 19–21 Jan 1983. Medicine Publishing Foundation, Oxford, p 111Google Scholar
  15. 15.
    Giannetti A, Lembo G,Zanoletti T et al. (1984) Il disodiocromoglicato nella dermatite atopica. G Ital Dermatol Venereol 119: 365PubMedGoogle Scholar
  16. 16.
    Burks AW, Sampson HA (1988) Double-blind placebo-controlled trial of oral cromolyn in children with atopic dermatitis and documented food hypersensitivity. J Allergy Clin Immunol 81: 471Google Scholar
  17. 17.
    Shaw RF (1975) Cromolyn therapy in chronic infantile eczema. Arch Dermatol 3: 1537CrossRefGoogle Scholar
  18. 18.
    Molkhou P, Waguet JC (1979) Oral disodium cromoglycate in the treatment of atopic eczema in children. In: Pepys J, Edwards AM (eds) The mast cell: its role in health and disease. Pitman Medical, Bath, p 617Google Scholar
  19. 19.
    Cavagni G, Paganelli R, Rigoli E (1985) SCG effect on macromolecular absorption of food antigens in atopic dermatitis ( AD ). Pediatr Res 19: 1119Google Scholar
  20. 20.
    Molkhou P, Waguet JC (1982) Atopic dermatitis in children and food allergy. Mechanisms of action of oral sodium cromoglycate. Communication 2nd International Symposium on Immunological and Clinical Problems of Food Allergy. Milan, Italy, Oct 1982Google Scholar
  21. 21.
    Graham P, Hall-Smith SP, Harris JM et al (1984) A study of hypoallergenic diets and oral sodium cromoglycate in the management of atopic eczema. Br J Dermatol 110: 457PubMedCrossRefGoogle Scholar
  22. 22.
    Boner AL, Valletta EA, Antolini I et al (1985) Trattamento della dermatite atopica con sodiocromoglicato in bambini non selezionati per allergia alimentare. Minerva Pediatr 37: 263PubMedGoogle Scholar
  23. 23.
    CorriasA, Rossi G, Orani Set al (1985)Terapia con DSCG nell’allergia alimentare dell’infanzia. Minerva Pediatr 37: 453Google Scholar
  24. 24.
    Oehling A, Ona J, Wierna G et al. (1985) The inhibitory effect of ketotifen on in vitro histamine release in allergic patients. Allergol Immunopathol (Madr) 13: 475Google Scholar
  25. 25.
    Craps LP (1985) Immunologic and therapeutic aspects of ketotifen. J Allergy Clin Immunol 76: 389PubMedCrossRefGoogle Scholar
  26. 26.
    Morley J, Page CP, Mazzoni L et al. (1986) Effects of ketotifen upon responser to platelet activating factor. A basis for asthma prophylaxis. Ann Allergy 56: 335Google Scholar
  27. 27.
    Chung KF, Minette P, McCusker M, Barnes PJ (1988) Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man. J Allerg Clin Immunol 81: 1192CrossRefGoogle Scholar
  28. 28.
    Molkou P, Dupont C (1987) Ketotifen in prevention and therapy of food allergy. Ann Allergy 59: 187Google Scholar
  29. 29.
    André C (1986) Allergie alimentaire. Diagnostic objectif et test de l’efficacité thérapeutique par mesure de la perméabilité intestinale. Presse Méd 15: 105PubMedGoogle Scholar
  30. 30.
    Miyasoto M (1988) Effect of ketotifen on density distribution of eosinophils in patients with atopic dermatitis. Inflammation 8: 260Google Scholar
  31. 31.
    Neffen H, Oehling A, Subira ML (1980) A study of the protective effect of ketotifen in food allergy. Allergol Immunopathol (Madr) 8: 97Google Scholar
  32. 32.
    Romanski B, Kurek M, Swiatkowski M (1982) Study of the protective action of Zaditen in cases of allergic disorders provoked by food allergy. In: Fuchs E, Halm D (eds) Asthma bronchiale, bronchiale Übererregbarkeit, Asthma Prophylaxe. Schattauer, Stuttgart, p 111Google Scholar
  33. 33.
    Boner AL, Richelli C, Antolini I et al. (1986) The efficacy of ketotifen in a controlled double-blind food challenge study in patients with food allergy. Ann Allergy 57: 61PubMedGoogle Scholar
  34. 34.
    Fiocchi A, Riva E, Borella E et al (1985) Ketotifen treatment of atopic dermatitis in childhood. CurrTher Res 37: 1113Google Scholar
  35. 35.
    Benincori L, Ferrara M, Cantani A et al. (1988) Valutazione dell’efficacia del chetotifene nella prevenzione dell’ esacerbazione della dermatite atopica da intolleranza alimentare del bambino. Folia Allergol Immunol 35: 399Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • L. Businco
  • A. Cantani

There are no affiliations available

Personalised recommendations